The principal goal of the Pilot/Exploratory Studies Core (PESC) is to foster high-quality, innovative, investigator-initiated research """"""""Translational Research on Cardiac and Skeletal Muscle Dysfunction in Aging and Disease"""""""". Such studies may be designed to prevent and/or treat morbidity and mortality associated with cardiac and skeletal muscle weakness and its sequelae. This will be achieved by funding pilot and exploratory studies that have the highest potential In terms of generating data, resulting in influential publications, and culminating in extramural funding. Such studies are thus deemed likely to advance the careers of promising scientists entering this field. Activities of the PESC will contribute to the overall goals of the Arkansas Older Americans Independence Center (OAiC) by strengthening research programs that focus on aging cardiac and skeletal muscle weakness and nutrition as one of the key interventions. By offering pilot grant support and strong mentoring opportunities, the PESC will provide a valuable mechanism for junior investigators to overcome the initial hurdles to securing research funds and to help propel their careers in research intended to improve outcomes for older adults. It will also help us to attract senior investigators from other disciplines to the intersection of research on striated muscle (both cardiac and skeletal) and nutrient supplementation. We are fortunate to have received ten excellent proposals, both from senior, internationally recognized scientists, who are poised to enter this area of investigation, and from exceptional young investigators starting on their career goals. Martin Hauer-Jensen, MD, PhD, an outstanding clinical researcher at the University of Arkansas for Medical Sciences (UAMS), exemplifies the first category;he has proposed to study the physiological basis for restoration of skeletal muscle mass and strength following arginine supplementation in human subjects. Two junior-faculty researchers were also selected: Anna Csiszar, MD, PhD, of the University of Oklahoma, will investigate the effects of arginine supplementation on cardiac and skeletal muscle function in rodents, and Sharda Singh, PhD (UAMS), proposes to study the metabolic changes underlying sarcopenia and ectopic fat accumulation in skeletal and cardiac muscle of aging mice. These three proposals were selected by the Internal Review and Executive Committee members from UAMS and OUHSC. This proposal review committee was guided by the same selection criteria presented in this proposal: high quality of proposed science, translational potential, congruence with the goals of the Arkansas OAIC, likelihood that PESC support will lead to extramural funding, and full utilization of cores RC1, RC2 and RC3.

Public Health Relevance

The PESC will contribute to the overall goals of the Arkansas OAIC, by strengthening programs that focus on translational research in geriatrics and muscle maintenance or repair. By offering pilot grant support and strong mentoring opportunities, the PESC will provide a valuable mechanism for junior investigators to overcome the initial hurdles to securing research funds and help propel their careers in translational research on cardiac and skeletal muscle dysfunction In aging and disease. It will also help us attract senior Investigators and further accelerate the pace of research in these areas.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG028718-04
Application #
8726258
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Type
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Zhang, Xiaomin; Williams, Emmanuel D; Azhar, Gohar et al. (2016) Does p49/STRAP, a SRF-binding protein (SRFBP1), modulate cardiac mitochondrial function in aging? Exp Gerontol 82:150-9
Alagpulinsa, David A; Ayyadevara, Srinivas; Yaccoby, Shmuel et al. (2016) A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition. Mol Cancer Ther 15:241-50
Kim, Il-Young; Schutzler, Scott; Schrader, Amy et al. (2016) The anabolic response to a meal containing different amounts of protein is not limited by the maximal stimulation of protein synthesis in healthy young adults. Am J Physiol Endocrinol Metab 310:E73-80
Carvalho, Eugenia; Lopaschuk, Gary D; Børsheim, Elisabet et al. (2016) Reply to Katlandur, Ozbek, and Keser. Am J Physiol Endocrinol Metab 310:E863
Baum, Jamie I; Kim, Il-Young; Wolfe, Robert R (2016) Protein Consumption and the Elderly: What Is the Optimal Level of Intake? Nutrients 8:
Deak, Ferenc; Freeman, Willard M; Ungvari, Zoltan et al. (2016) Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment. J Gerontol A Biol Sci Med Sci 71:13-20
Tarantini, Stefano; Giles, Cory B; Wren, Jonathan D et al. (2016) IGF-1 deficiency in a critical period early in life influences the vascular aging phenotype in mice by altering miRNA-mediated post-transcriptional gene regulation: implications for the developmental origins of health and disease hypothesis. Age (Dordr) 38:239-258
Perry Jr, Richard A; Brown, Lemuel A; Lee, David E et al. (2016) Differential effects of leucine supplementation in young and aged mice at the onset of skeletal muscle regeneration. Mech Ageing Dev 157:7-16
Tarantini, Stefano; Tucsek, Zsuzsanna; Valcarcel-Ares, M Noa et al. (2016) Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. Age (Dordr) 38:273-289
Penthala, Narsimha Reddy; Yadlapalli, Jaishankar K B; Parkin, Sean et al. (2016) Crystal structures of (Z)-5-[2-(benzo[b]thio-phen-2-yl)-1-(3,5-di-meth-oxy-phen-yl)ethen-yl]-1H-tetra-zole and (Z)-5-[2-(benzo[b]thio-phen-3-yl)-1-(3,4,5-tri-meth-oxy-phen-yl)ethen-yl]-1H-tetra-zole. Acta Crystallogr E Crystallogr Commun 72:652-5

Showing the most recent 10 out of 62 publications